Literature DB >> 8769810

Activation and selectivity of splenic sympathetic nerve electrical activity response to bacterial endotoxin.

B J MacNeil1, A H Jansen, A H Greenberg, D M Nance.   

Abstract

Regulatory interactions and neuroanatomic pathways have been described between the sympathetic nervous system and the immune system. It is not clear whether these pathways are activated during immune responses and if target specificity provides selective regulation of immune organs. The present study examined whether systemic injection of endotoxin [lipopolysaccharide (LPS)] induces sympathetic outflow to an immune organ (spleen). Sympathetic nerve activity was recorded from either the splenic or renal nerve of adult male rats after intravenous injections of LPS. Splenic nerve activity increased in a dose-dependent manner up to 175% of control after injection of LPS, with an onset time of 17.1-23.5 min. In contrast, renal nerve recordings showed a significantly slower onset time of 37.1-52.6 min at similar doses. In addition, splenic nerve recordings of 8/8 rats responded to 10 micrograms of LPS, whereas only 4/11 positive renal nerve responses were observed at this dose. The magnitude of the responses of both splenic and renal nerves were comparable. These data suggest that the splenic nerve responds to and is more sensitive to LPS-stimulated sympathetic activation in terms of latency and frequency of responses. Thus sympathetic outflow can be directed to an immune organ in response to a stimulus known to activate the immune system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769810     DOI: 10.1152/ajpregu.1996.270.1.R264

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen.

Authors:  M Bakhiet; L-Y Yu; V Ozenci; A Khan; F-D Shi
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 2.  Somatosensory and autonomic neuronal regulation of the immune response.

Authors:  Swalpa Udit; Kimbria Blake; Isaac M Chiu
Journal:  Nat Rev Neurosci       Date:  2022-01-07       Impact factor: 38.755

3.  Compromised neuroimmune status in rats with experimental colitis.

Authors:  Lysa Boissé; Marja D Van Sickle; Keith A Sharkey; Quentin J Pittman
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

Review 4.  Neural pathways involved in infection-induced inflammation: recent insights and clinical implications.

Authors:  Marion Griton; Jan Pieter Konsman
Journal:  Clin Auton Res       Date:  2018-03-14       Impact factor: 4.435

5.  Serum from exercising humans suppresses t-cell cytokine production.

Authors:  Shlomit Radom-Aizik; Szu-Yun Leu; Dan M Cooper; Frank Zaldivar
Journal:  Cytokine       Date:  2007-10-04       Impact factor: 3.861

6.  Central nervous system administration of interleukin-6 produces splenic sympathoexcitation.

Authors:  Bryan G Helwig; Robin A Craig; Richard J Fels; Frank Blecha; Michael J Kenney
Journal:  Auton Neurosci       Date:  2008-06-10       Impact factor: 3.145

7.  The initial fall in arterial pressure evoked by endotoxin is mediated by the ventrolateral periaqueductal gray.

Authors:  William R Millington; M Sertac Yilmaz; Carlos Feleder
Journal:  Clin Exp Pharmacol Physiol       Date:  2016-06       Impact factor: 2.557

Review 8.  Role of adrenergic receptor signalling in neuroimmune communication.

Authors:  Sushanta Chhatar; Girdhari Lal
Journal:  Curr Res Immunol       Date:  2021-11-25

Review 9.  Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?

Authors:  Denise L Bellinger; Dianne Lorton
Journal:  Int J Mol Sci       Date:  2018-04-13       Impact factor: 5.923

Review 10.  Molecular mechanisms underlying β-adrenergic receptor-mediated cross-talk between sympathetic neurons and immune cells.

Authors:  Dianne Lorton; Denise L Bellinger
Journal:  Int J Mol Sci       Date:  2015-03-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.